Free · Female genital tract · updated to WHO 6th edition (2026)
Gynae pathology MCQs, the WHO 6th edition way.
15 board-style questions on the 6th edition Female Genital Tumours: HPV-independent VIN and CIN, STK11 adnexal tumour, SMARCB1-deficient vulvar neoplasms, FIGO 2023 molecular staging and molecularly defined uterine sarcomas. Every answer explains why the other options are wrong.
Enter your details to start
We will send you new cases and free question banks. One quick form unlocks every Pathology MCQ quiz on this device.
No spam. Unsubscribe any time.
How do you want to practise?
Pick one. You can switch later by starting again.
Go further with a course
The Pathology MCQ app
A slide and an MCQ every day
Daily MCQ with streaks, pinch-zoom virtual slides with annotations, and your courses in one place.
Free account
Save your scores and get more free banks
Create a free Pathology MCQ account to track your progress across question banks and get new quizzes first.
WHO Female Genital 6th ed (2026) · what you will practise
What this gynaecological pathology quiz covers
The questions follow the 6th edition WHO Classification of Female Genital Tumours (2026, beta), with its new and renamed entities, together with FIGO 2023 molecular staging of endometrial cancer and current molecular testing.
What is new in the 6th edition
HPV-independent VIN and the new HPV-independent cervical intraepithelial neoplasia, ‘HPV status undetermined’ squamous carcinoma, STK11 adnexal tumour and SMARCB1-deficient vulvar neoplasms.
FIGO 2023 molecular staging
POLE-mutated stage IAmPOLEmut and p53-abnormal stage IICmp53abn in endometrial cancer.
Cervix and vulva
HPV-associated versus HPV-independent tumours, gastric-type adenocarcinoma and STK11, Silva pattern.
Ovary
p53 patterns in high-grade serous carcinoma and mesonephric-like carcinoma.
Mesenchymal tumours
High-grade endometrial stromal sarcoma fusions, FH-deficient leiomyoma and HLRCC, SMARC-deficient sarcoma.
Predictive testing
HER2 testing in uterine serous carcinoma.
Frequently asked questions
Is this quiz updated to the WHO 6th edition?
Yes. Five questions cover new and renamed entities in the WHO Classification of Female Genital Tumours, 6th edition (2026), and the rest cover FIGO 2023 staging and molecular testing. Each explanation cites its source.
Who is it for?
Candidates preparing for INI-SS, NEET-SS and DM Oncopathology, FRCPath Part 1 and Part 2, and MD/DNB pathology, as well as practising pathologists keeping up to date.
Can I see the answer after each question?
Yes. Choose Learn mode to see the answer and explanation after each question, or Test mode to answer all 15 first and review the explanations with your score at the end.
Is the quiz free?
Yes. Enter your name and email once to start; if you are logged in to Pathology MCQ you go straight in.
The Pathology MCQ app
Keep practising every day, wherever you are
High-yield, board-style image MCQs and interactive whole slide images for FRCPath, NEET-SS, INI-SS, DM and MD/DNB, in your pocket.
- A daily MCQ with current and longest streaks
- Pinch-zoom virtual slides, with annotations that point to the answer
- Your courses, question banks and progress in one place